Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 44(2); 2023 > Article
seo: The Review of Domestic Research on Traditional Korean Medicine for Gastroesophageal Reflux Disease

Abstract

This study was conducted to examine the current status of traditional korean medicine studies on gastroesophageal reflux disease in Korea, identify deficiencies, and suggest the direction of future medicine research methods to lay the foundation for traditional korean medicine treatment. All domestic papers on the korean traditional treatment of gastroesophageal reflux disease were selected among the literature published until August 2022 in six domestic databases. A total of 52 selected research data were classified into experimental research papers, clinical research papers, and review papers. In experimental papers, to evaluate the effectiveness of treatment, improvement of esophageal mucosal lesions, anti-inflammatory mechanisms, antioxidant mechanisms, esophageal mucosal protection mechanisms, gastric peristalsis control, and gastric acid secretion inhibition mechanisms were used as evaluation measures. In the clinical research paper, the basis for diagnosis of cases was clinical symptoms through medical history listening and diagnosis through visits to hospitals in the past. The average treatment period was 40.7 days, and the duration of treatment was not significantly affected by the duration of the disease. The most widely used Korean medicine treatment intervention was herbal medicine. There were 3 literature review studies, 3 systematic literature review and meta-analysis studies, 1 comparative review study for clinical trial guideline development, all using Chinese papers. This study included all domestic papers on gastroesophageal reflux disease to identify the research trend of the Korean oriental medicine community, and based on this, it is meaningful to confirm areas that need to be supplemented in future research plans.

Fig. 1
Flow diagram of the selection process.
jkm-44-2-70f1.gif
Table 1
The List of In Vivo/Vitro Studies
Author Year Title Journal
Nam HH17) 2022 Crab Water Extrct Amelorates Reflux Esophagitis in Rats Herbal Formula Science
Lee SH18) 2021 The Protective Effect of Arecae Semen and Coptidis Rhizoma in a Chronic Reflux Esophagitis Rat Model J. Int. Korean Med
Lee JA19) 2021 Effects of a mixture of Citri Pericarpium and Scutellariae Radix on acuterefluxesophagitisinrats J Nutr Health
Lee JA20) 2021 Effect of Toosendan Fructus on Chronic Acid Reflux Esophagitis Rats Kor. J. Herbology
Lee JA21) 2020 Effect of a Mixture of Rhei Rhizoma and Scutellariae Radix Extract on Acute Reflux Esophagitis Rat Kor. J. Herbol.
Lee SH22) 2020 The Protective Effect of Water Extract of Phellodendri Cortex in Chronic Reflux Esophagitis-induced Rats Kor. J. Herbol.
Lee JA23) 2020 Effect of Coptidis Rhizoma and Evodiae Fructus Mixture on Esophageal Mucosa in Chronic Reflux Esophagitis Kor. J. Pharmacogn.
Nam HH24) 2020 Effect on rat model of reflux esophagitis treated with Charybdis japonica extract Kor. J. Herbol.
Shin MR25) 2020 The protective effect of Areca Semen and Toosendan Fructus mixture in a chronic model of reflux esophagitis Kor. J. Herbol.
Lee SH26) 2019 A Comparative Study on the Effects of Pinellia ternata, Zingiber officinale and Sobanhatang on Reflux Esophagitis J Korean Med
Lee JA27) 2019 Evaluation of Evodiae Fructus Extract on the Chronic Acid Reflux Esophagitis in Rat Kor. J. Herbology
Kim SH28) 2019 Improving Effects on Rats with Chronic Acid Reflux Esophagitis Treated of Coptidis Rhizoma Extract Kor. J. Herbology
Song CH29) 2018 A Comparative Study of Sepiae Os, Arcae Concha, Ostreae Concha and Esomeprazole in a Mouse Model of Reflux Esophagitis J Korean Med
Kwon OJ30) 2016 Improving Effects on Rats with Reflux Esophagitis Treated with Combined Extract of Young persimmon fruit and Citrus peel Kor. J. Herbol.
Shin MH31) 2016 Suppressive Effects of Ulmi Pumilae Cortex Extracts on the Reflux Esophagitis in Rat Korean J. Oriental Physiology & Pathology
Lee JY32) 2016 Improving effect of Artemisiae Capillaris Herba extract in reflux esophagitis rats Kor. J. Herbology
Shin MK33) 2016 Effects of Jwa Kum-Whan on Reflux Esophagitis in Rats J. Int. Korean Med
Lee SK34) 2016 The Administration of Jeungmiyijin-tang to Rats with Induced Gastro Reflux Esophagitis J. Int. Korean Med
Kim MY35) 2015 Improving Effect of a Combined Extract of Rhei Rhizoma and Glycyrrhizae Rhizoma through Anti-oxidative Stress in Reflux Esophagitis rats Kor. J. Herbol.
Lee ST36) 2013 Effects of Individual Herbal Components of Yijintang-gamibang in the Rat Reflux Esophagitis J. Int. Korean Med
Choi YJ37) 2013 Inhibitory Effects of Naegwan-acupuncture(PC6) on Acute Reflux Esophagitis Rat Journal of Korean Acupuncture & Moxibustion Medicine Society
Jang MW38) 2013 Experimental Study for Effect of Banhasasim-tang on Mice with Reflux Esophagitis J. Int. Korean Med
Kim DJ39) 2012 Effect on Acute reflux Esophagitis by Evodiae Fructus Aquous Extracts Kor. J. Herbology
Kim HJ40) 2010 Effects of Yijintang-gamibang on Reflux Esophagitis Induced by Pylorus and Forestomach Ligation in Rats J. Int. Korean Med
Lee YJ41) 2020 Effects on Rats with Reflux Esophagitis Treated with Lonicerae Flos Extract Korean J. Oriental Physiology & Pathology
Park K42) 2010 Protective Effects of Yijin-tang-gamibang Aqueous Extracts on Reflux Esophagitis Mediated by Antioxidant Defense System Korean J. Oriental Physiology & Pathology
Table 2
The List of Clinical Researches
Author Year Title Journal
Case report
Kim MS43) 2021 A Case Report of Taeumin Patient with Gastroesophageal reflux disease Treated with Taeumin Cheongsimyeonja-tang J. Sasang Constitut Med
Kim SW44) 2021 A Case Report on Reflux Esophagitis Treated with Korean Medicine in a Patient with Spinal Stenosis J. Int. Korean Med
Jun HJ45) 2020 A Case Report of Non-cardiac Chest Pain in a Non-erosive Reflux Disease Patient Treated with Beewha-eum J. Int. Korean Med
Na GY46) 2017 A Case Report on Soojeom-san plus Jeungmiyijin-tang for Treatment of Gastroesophageal Reflux Disease with Hiatal Hernia J. Int. Korean Med
Lee JH47) 2017 Clinical Case Report of PPI-refractory Gastro-Esophageal Reflux Disease (GERD) with Korean Medicine Treatment - A Focus on Evaluation of the Abdominal Examination J. Int. Korean Med
Yoon SH48) 2016 A Clinical Case Report of Endoscopic Reflux Esophagitis with Gastric
Dysmotility
Treated with Korean Traditional Medical Therapy
J. Int. Korean Med
Kim YJ49) 2016 A Case Report of Gastroesophageal Reflux Disease and Dysphagia Caused by Ingestion of Detergent J. Int. Korean Med
Kim YH50) 2011 A Case Study of Taeumin Patient with Gastro-esophageal reflux disease(GERD) who Treated Successfully with Yeoldahanso-tang(Reduohanshao-tang) J. Sasang Constitut Med
Park JW51) 2006 A Clinial Case Report of Non-erosive Reflux Disease Treated with Traditional Oriental Medicine J. Int. Korean Med
Lee JE52) 2005 A Case Report of Gastroesophageal Reflux(GERD) with Hiatal Hernia J. Int. Korean Med
Baek DG53) 2004 Clinical Study on 1 Case of Reflux Esophagitis Korean J. Oriental Physiology & Pathology
Case series
Lee JH54) 2017 Case Study of Three Gastro-esophageal Reflux-induced Chronic Cough Patients Treated with Ojeok-san plus Saengmaek-san J. Int. Korean Med
Ha NY55) 2017 Case Series of Refractory Gastroesophageal Reflux Disease Treated with Lijin-tang-gamibang J. Int. Korean Med
Lim TH56) 2015 2 Case Reports of Gastroesophageal Reflux Disease Diagnosed as Soyangin
Mangeum
J. Sasang Constitute Med
Kim MJ57) 2015 A Case Study of 4 Patients with Reflux Esophagitis Who Had Improved Gastroesophageal Reflux Disease after Treatment with SokPyeonAnGel J. Int. Korean Med
Kim BS58) 2005 Seven Cases of Non-Erosive Gastroesophageal Reflux Disease Who were Treated by Lijintang-Gamibang and Acupuncture J. Int. Korean Med
Assessment scales study
Han GJ59) 2015 Development of a Standard Tool for Pattern Identification of Gastroesophageal Reflux Disease(GERD) J. Int. Korean Med
Choi YJ60) 2022 A Study of the Reliability and Validity of Standard Tools for the Pattern Identification of Gastroesophageal Reflux Diseas J. Int. Korean Med
Comparative study
Baek SY61) 2019 Comparison of the Clinical Characteristics of Patients with Gastroesophageal Reflux
Disease According to Globus Sensation
J. Int. Korean Med
Table 3
In Vivo/Vitro Studies about Gastroesophageal Reflux Disease on Traditional Medicine
Author (year) Animal Medication Route & period main outcome measures Results
Nam17) (2022)
vitro, vivo
Sprague-Dawley Rats (n=18)
Pylorus and forestomach ligation operation-induced RE
lipopolysaccharide induced Raw 264.7 cell
crab water extract (CWE) Oral pre-treated with 100 mg/kg CWE 1h before surgery
  • ① NO production (cell)

  • ② esophageal mucosa damage area

  • ③ COX-2, TNF-α

  • ④ NF-κB, IκB-α

  • ① suppressed

  • ② decreased

  • ③ decreased

  • ④ decreased

Lee18) (2021)
vitro, vivo
Sprague-Dawley Rats (n=not reported) Arecae Semen and Coptidis Rhizoma mixture (AC-mix)
1:2.5
Oral (1회/day), 2 weeks
  • ① total polyphenol, total flavonoid

  • ② DPPH, ABTS scavenging activity

  • ③ esophageal mucosa damage area

  • ④ NF-κBp65

  • ⑤ COX-2, iNOS

  • ⑥ HO-1, Nrf2-Keap1

  • ⑦ MMP-2

  • ⑧ TIMP-1, TIMP-2

  • ① showed a high content

  • ② high antioxidant activities

  • ③ reduced

  • ④ inhibited

  • ⑤ inhibited

  • ⑥ increased

  • ⑦ decreased

  • ⑧ elevated

Lee19) (2021)
vitro, vivo
Sprague-Dawley Rats (n=40)
Pylorus and forestomach ligation operation-induced RE
Citri Pericarpium and Scutellariae Radix (CS)
1:1
Oral pre-treated 90 min before surgery
  • ① esophageal mucosal damage area

  • ② ROS

  • ③ NADPH (NOX4, P47 phox)

  • ④ MAPK (c-Fos, c-Jun, p-p38, p-ERK, p-JNK)

  • ⑤ NF-κBp65, p-IκBα, COX-2, TNF-α, IL-6

  • ⑥ claudin-1, claudin-4

  • ① reduced

  • ② reduced

  • ③ reduced

  • ④ reduced

  • ⑤ reduced

  • ⑥ increased

Lee20) (2021)
vitro, vivo
Sprague-Dawley Rats (n=16)
Pylorus and forestomach ligation operation-induced RE
Toosendan Fructus Oral (1회/day),2 weeks
  • ① total polyphenol, total flavonoid

  • ② esophageal mucosal damage area

  • ③ NADPH oxidases, AP-1/MAPK (c-Fos, c-Jun, p-p38, p-ERK, p-JNK)

  • ④ Occludin, Claudin-3, Claudin-4

  • ① showed a high content

  • ② reduced

    • ③ reduced

  • ④ increased

Lee21) (2020)
vitro, vivo
Sprague-Dawley Rats (n=40)
Pylorus and forestomach ligation operation-induced RE
Mixture of Rhei Rhizoma and Scutellariae Radix Extract
1:1
Oral pre-treated before surgery
  • ① esophageal mucosal damage area

  • ② ROS, AST, ALT

  • ③ NADPH, MAPK, NF-κBp65, p-IκBα, COX-2, TNF-α, IL-6, IL-4, IL-10

  • ④ Claudin-1, Claudin-3, Claudin-4

  • ① reduced

  • ② reduced

  • ③ reduced

  • ④ increased

Lee22) (2020)
vitro, vivo
Sprague-Dawley Rats (n=not reported)
Pylorus and forestomach ligation operation-induced RE
Water Extract of Phellodendri Cortex Oral (1회/day), 2 weeks
  • ① esophageal mucosal damage area

  • ② total polyphenol, total flavonoid

  • ③ DPPH, ABTS radical scavenging activities

  • ④ ROS, ONOO-, iNOS

  • ⑤ NADPH oxidases : NOX4, p47phox, p22phox

  • ⑥ TNF-α, IL-6, NF-κBp65, p-IκBα

  • ⑦ HO-1, SOD, catalase, GPx-1/2, Nrf2

  • ① reduced

  • ② showed a high content

  • ③ high antioxidant activities

  • ④ reduced

  • ⑤ reduced

  • ⑥ reduced

  • ⑦ increased

Lee23) (2020)
vitro, vivo
Sprague-Dawley Rats (n=not reported)
Pylorus and forestomach ligation operation-induced RE
Coptidis Rhizoma and Evodiae Fructus Mixture
1:1, 1:2
Oral (1회/day), 2 weeks
  • ① DPPH, ABTS radical scavenging activities

  • ② esophageal mucosal damage area.

  • ③ NADPH Oxidase (NOX4, p47phox)

  • ④ Nrf2, Keap-1

  • ⑤ MAPKs (c-Fos, c-Jun, p-p38, p-ERK, p-JNK)

  • ⑥ NF-κBp65, p-IκBα iNOS, COX-2, TNF-α, IL-6

  • ⑦ MMP-2, MMP-8

  • ⑧ ZO-1, occludin, claudin-1, claudin-4

  • ① high antioxidant activities

  • ② reduced

  • ③ reduced

  • ④ increased

  • ⑤ reduced

  • ⑥ reduced

  • ⑦ reduced

  • ⑧ reduced

Nam24) (2020)
vitro, vivo
Sprague-Dawley Rats (n=20)
Pylorus and forestomach ligation operation-induced RE
Charybdis japonica extract Oral pre-treated before surgery
  • ① esophageal mucosal damage 4area

  • ② claudin-5

  • ③ COX-2, TNF-, NF-κB, p-IκBα

  • ① reduced

  • ② protected

  • ④ reduced

Shin25) (2020)
vitro, vivo
Sprague-Dawley Rats (n=not reported)
Pylorus and forestomach ligation operation-induced RE
Areca Semen and Toosendan Fructus mi5xture Oral (1회/day), 2 weeks
  • ① DPPH, ABTS radical scavenging activity

  • ② esophageal mucosal damage area

  • ③ NADPH oxidase (NOX4, p22phox)

  • ④ Nrf2, HO-1, SOD, Catalase, GPx-1/2

  • ⑤ NF-κB(p-IκBα, NF-κBp65), COX-2, iNOS, TNF-α, IL-6

  • ① high antioxidant activities

  • ② reduced

  • ③ reduced

  • ④ increased

  • ⑤ decreased

Lee26) (2019)
vitro, vivo
Sprague-Dawley Rats (n=60)
Pylorus and forestomach ligation operation-induced RE
Pinellia ternata (PT), Zingiber officinale (ZE), Sobanhatang water extract (SBT) Oral (1회/day), 2 weeks
  • ① DPPH radical scavenging activity

  • ② HO-1

  • ③ ghrelin

  • ④ gastrin

  • ⑤ substance P

  • ⑥ mucosal barrier damage

  • ⑦ distribution of mast cells and inflammatory cells

  • ① increased, Ascorbic acid > ZE > PT > SBT

  • ② increased, ZT > SBT > PT

  • ③ increased, ZT> ET > SBT

  • ④ decreased, PT > SBT

  • ⑤ decreased, PT > SBT

  • ⑥ decreased, PT > SBT > ZT

  • ⑦ decreased, ZT > SBT > PT

Lee27) (2019)
vitro, vivo
Sprague-Dawley Rats (n=not reported)
Pylorus and forestomach ligation operation-induced RE
Evodiae Fructus Extract Oral (1회/day), 2 weeks
  • ① Total polyphenol, total flavonoid

  • ② DPPH, ABTS radical scavenging activity

  • ③ esophagus mucosal damage area

  • ④ ROS, ONOO-

  • ⑤ NF-κBp65, p-IκBα, iNOS, TNF-α, IL-6

  • ⑥ Nrf2, HO-1, SOD, catalase, GPx-1/2

  • ① showed high contents

  • ② high antioxidant activities

  • ③ reduced

  • ④ decreased

  • ⑤ reduced

  • ⑥ increased

Kim28) (2019)
vitro, vivo
Sprague-Dawley Rats (n=not reported)
Pylorus and forestomach ligation operation-induced RE
Coptidis Rhizoma Extract Oral (1회/day), 2 weeks
  • ① DPPH, ABTS radical scavenging activity

  • ② esophagus mucosal damage area

  • ③ Nrf-2, HO-1, SOD, catalase, GPx-1/2

  • ④ ONOO-, NF-κBp65, p-IκBα, iNOS, IL-6.

  • ① high antioxidant activities

  • ② improved

  • ③ increased

  • ④ reduced

Song29) (2018)
vitro, vivo
RAW 264.7 cell
BALB/c Rats (n=50)
induced by gastric juice
Sepiae Os, Arcae Concha, Ostreae Concha Oral (1회/day), 2 weeks
  • ① NO production, iNOS mRNA expression level(vitro)

  • ② iNOS, p-IκB, TNF-α

  • ③ serotonin

  • ④ esophagus mucosal damage area

  • ⑤ IL-6

  • ① decreased

  • ② suppressed (SOT,OCT)

  • ③ increased (ACT,MT,OCT)

  • ④ less (SOT,ACT,OCT)

  • ⑤ suppressed (SOT,OCT)

Kwon30) (2016)
vitro, vivo
Sprague-Dawley Rats (n=24)
Pylorus and forestomach ligation operation-induced RE
Combined Extract of Young persimmon fruit and Citrus peel Oral pre-treated before surgery
  • ① esophageal mucosa damage area

  • ② ROS, ONOO-

  • ③ SOD, catalase, GPx

  • ④ COX-2, iNOS, TNF-α, IL-6

  • ⑤ NFκB, p-IκBα

  • ① decreased

  • ② decreased

  • ③ increased

  • ④ reduced

  • ⑤ decreased

Shin31) (2016)
vitro, vivo
Sprague-Dawley Rats (n=40)
Pylorus and forestomach ligation operation-induced RE
Ulmi Pumilae Cortex Extracts Oral (1회/day), 2 weeks
  • ① Gastric volume

  • ② Mucosa damage

  • ③ SOD, catalase

  • ① decreased

  • ② decreased

  • ③ increased.

Lee32) (2016)
vitro, vivo
Sprague-Dawley Rats (n=24)
Pylorus and forestomach ligation operation-induced RE
Artemisiae Capillaris Herba extract Oral pre-treated before surgery
  • ① Total polyphenol and total flavonoid

  • ② DPPH, ABTS radical scavenging activity

  • ③ ROS, p-IκBα, NF-κBp65, COX-2, iNOS, TNF-α

  • ④ esophageal mucosa damage area.

  • ① high contents

  • ② high antioxidant activities

  • ③ decreased

  • ④ decreased

Shin33) (2016)
vitro, vivo
Sprague-Dawley Rats (n=40)
Pylorus and forestomach ligation operation-induced RE
Jwa Kum-Whan (Coptidis Rhizoma 240g, Evodiae Fructus 40g) Oral (1회/day), 2 weeks
  • ① gastric juice pH

  • ② gastric volume

  • ③ SOD, Catalase

  • ④ TNF-α, IL-6

  • ⑤ esophageal mucosa damage area

  • ① increased

  • ② decreased

  • ③ increased

  • ④ decreased

  • ⑤ decreased

Lee34) (2016)
vitro, vivo
Sprague-Dawley Rats (n=12)
Pylorus and forestomach ligation operation-induced RE
Jeungmiyijin-tang (Pinelliae Rhizoma 4 Citri Pericarpium 4 Holelen 4 Gardeniae Fructus 4 Coptidis Rhizoma 4 Cyperi Rhizoma 4 Ponciri Fructus Immaturus 3 Cnidii Rhizoma 3 Atractylodis Rhizoma 3 Paeoniae Radix 3 Massa Medicata Fermentata 2 Glycyrrhizae Radix 1) Oral (1회/day), 2 weeks
  • ① esophageal mucosa damage area

  • ② mast cells, IL-1β, TNF-α, MMP-9.

  • ③ Apoptosis

  • ① decreased

  • ② reduced

  • ② decreased

Kim35) (2015)
vitro, vivo
Sprague-Dawley Rats (n=18)
Pylorus and forestomach ligation operation-induced RE
Combined Extract of Rhei Rhizoma and Glycyrrhizae Rhizoma 15g Oral pre-treated before surgery
  • ① DPPH, ABTS scavenging activity

  • ② esophageal mucosa damage area

  • ③ ROS, ONOO-, TABARS

  • ④ Nrf2, HO-1

  • ⑤ IκBα, NF-κB p65, COX-2, iNOS, TNF-α, IL-6

  • ① high antioxidant activities

  • ② reduced

  • ③ decreased

  • ④ increased

  • ⑤ decreased

Lee36) (2013)
vitro, vivo
Sprague-Dawley Rats (n=88)
Pylorus and forestomach ligation operation-induced RE
Individual Herbal Components of Yijintang-gamibang (Pinella Rhizoma, Citri Pericarpium, Holelen, Atractylodis Rhizoma, Massa Meicata Fermentata, Hordei Fructus Germiniatus, Coptidis Rhizoma, Glycyrrhizae Radix) Oral pre-treated twice (1hr before and 6hrs after surgery)
  • ①esophageal mucosa damage area

  • ②gastric volumes

  • ③gastric acid and pepsin outputs

  • ④MDA, SOD, GSH

  • ⑤total hexose, sialic acid

  • ① decreased

  • ② decreased

  • ③ decreased

  • ④ increased

  • ⑤ increased (only in CP,H, AR,HFG,CR,GR)

Choi37) (2013)
vivo
Sprague-Dawley Rats (n=27)
Pylorus and forestomach ligation operation-induced RE
Naegwan-acupuncture(PC6) Four times an hour after surgery
  • ① death rate

  • ② gastric volume, gastric juice pH, gastric injury, esophageal mucosa injury

  • ③ TNF-α, IL-6, MCP-1

  • ① decreased

  • ② decreased

  • ③ decreased

Jang38) (2013)
vitro, vivo
ICR Rats (n=30)
50% ethyl alcohol-induced RE
Banhasasim-tang (Pinelliae Rhizoma 12 Scutellariae Radix 6 Zingiberis Rhizoma 6 Ginseng Radix 6 Glycyrrhizae Radix 6Jujubae Fructus 6 Coptidis Rhizoma 2) Oral (1회/day), 3 days
  • ① The migration of inflammation-related cells in GEJ

  • ② ghrelin, substance P, iNOS

  • ③ esophageal mucosa damage area

  • ① decreased

  • ② decreased

  • ③ decreased

Kim39) (2012)
vitro, vivo
Sprague-Dawley Rats (n=24)
Pylorus and forestomach ligation operation-induced RE
Evodiae Fructus Aquous Extract Oral pre-treated before surgery
  • ① esophageal damage percentage.

  • ② TNF-α, IL-1, IL-1β, and IL-6

  • ① decreased

  • ② decreased

Park40) (2010)
vitro, vivo
Sprague-Dawley Rats (n=56)
Pylorus and forestomach ligation operation-induced RE
Yijin-tang-gamibang Aqueous Extract ( Ephedrae Herba 16 Cinnamomi Ramulus 8 Platycodi Radix 8 Fritillariae Bulbus 8 Armeniacae Semen 8 Schizandrae Fructus 8 Gelatinum 8 Aurantii Immaturi Pericarpium 4) Oral (1회/day), 28 days
  • ①Esophageal Lipid Peroxidation

  • ② SOD, catalase, GSH

  • ③ total hexose, sialic acid

  • ④ histamine, collagen content

  • ⑤ esophageal mucosa damage area

  • ① suppressed

  • ② increased

  • ③ increased

  • ④ decreased

  • ⑤ decreased

Kim41) (2010)
vivo
Sprague-Dawley Rats (n=56)
Pylorus and forestomach ligation operation-induced RE
Yijintang-gamibang (Pinelliae Tube 16 Aurantii nobilis Pericarpium 8 Poria 8 Atractylodis Rhizoma 8 Massa Medicata Fermentat 8 Hordei Fructus Germinatus 8 Coptidis Rhizoma 8Glycyrrhizae Radix 4) Oral (1회/day), 28 days
  • ① esophageal mucosa damage area

  • ② gastric volume

  • ③ acid and pepsin output.

  • ① decreased

  • ② decreased

  • ③ decreased

Lee42) (2010)
vitro, vivo
Sprague-Dawley Rats (n=18)
Pylorus and forestomach ligation operation-induced RE
Lonicerae Flos Extract Oral (1회/day), 2 weeks
  • ① gastric volume

  • ② gastric acid and pepsin output

  • ③ hexose

  • ④ sialic acid

  • ⑤ serume histamine

  • ① decreased

  • ② decreased

  • ③ increased

  • ④ increased

  • ⑤ decreased

Table 4
Clinical Research about Gastroesophageal Reflux Disease
Author Sample size Treatment period Intervention Result
Case report
Kim43) (2021) M/30 (n=1) 22 days herbal decoction (Taeumin Cheongsimyeonja-tang), acupuncture (BL18, BL13, BL20, CV12, ST36, PC6, LR3) GSRS improved from 4.8 to 2.6.
Clinical symptoms of sore throat, cough, phlegm and bowel sound were improved.
Kim44) (2021) F/69 (n=1) 13 days herbal decoction (Jeonjeonggamiijin-tang Ga Cheongpi, Moryeobun, Baekjakyak), herbal extracts (Jakyakgamcho-tang, Opae-san), acupuncture, electroacupuncture (ST36-SP6) RSI and EQ-5d scores improved, but VAS scores showed that only heartburn, acid reflux, and chest pain symptoms were relieved.
Jun45) (2020) M/54 (n=1) 8 days herbal decoction (Beewha-eum), herbal extracts (Banhasasim-Tang), acupuncture (Ex-HN05, LI04, LR03, SP04, ST36, SP06), electroacupuncture(ST36-ST37), moxibustion (CV12, CV04) The severity of chest pain was decreased.
The self-reported dyspepsia degree also decreased.
KGSRS and GIS score was decreased.
FD-QOL score was increased.
Na46) (2017) M/34 (n=1) 12 days herbal decoction (Soojeom-san plus Jeungmiyijin-tang), acupuncture (CV13(上脘), CV12(中脘), CV10(下脘), ST36(足三里), SP6(三陰交), SP04(公孫), PC6(內關), moxibustion (CV12, CV4), cupping (BL20, BL21) Symptoms of GERD such as chest pain, heartburn, and acid regurgitation are almost disappeared.
The patient don’t need to take the proton pump inhibitor therapy.
There was significant increase of % bradygastria parameters in fed EGG.
And significant increase of the power ratio was shown.
Lee47) (2017) M/60 (n=1) 19 days herbal decoction (Gyejibanhasaenggang-tang, Guibi-tang), herbal extracts (Banhasasim-Tang), acupuncture (LI4, LR3, ST 36, EX-HN5), moxibustion (CV12, CV4) clinical symptoms were improved. VAS, GIS, and GSRS scores were improved.
Kim49) (2016) F/51 (n=1) 26 days herbal decoction (Anjoongsan-gami-bang, Samchulkunbi-tang-gami-bang, Banhahubak-tang-gami-bang), acupuncture (LI4, LR3, CV12, ST36, PC4, SP6, ST41), pharmacopuncture (Hwangnyeonhaedok-tang 0.4 cc ST9, ST10), moxibustion (CV12) the patient’s food intake increased and Numeric rating scale (NRS) scores of heart burning pain and dysphagia were diminished.
Yoon48) (2016) F/28 (n=1) 2012.4.10.~2012.8.9 (122 days)
2013.7.20.~2013.12.14 (148 days)
herbal decoction (pyeongyoe san-gami-bang), herbal extracts (Sojukgunbi-hwan), acupuncture (CV13, CV12, CV10, ST36), electroacupuncture(ST36), moxibustion (CV12) All the patients’symptoms had disappeared, and the mucosa of the esophagus had returned to normal.
Kim50) (2011) F/74 (n=1) 11 weeks herbal decoction (Yeoldahanso-tang), acupuncture (Ganseunggyeok), medication (proton pump inhibitor, first 3 weeks) Symptoms of GERD such as chest pain, heartburn, and acid regurgitation are almost disappeared.
The patient don’t need to take the proton pump inhibitor therapy.
There was significant increaseof % bradygastria parameters in fed EGG.
And significant increase of the power ratio was shown.
Park51) (2006) F/39 (n=1) 2 months herbal decoction (Bokryungyeum-tang), Herbal Formulae (Banhasasim-tang, Hyangsayangyi-tang, Opae-san, Sojukgunbi-hwan), acupuncture (LI4, ST36), moxibustion (CV4, CV12) Severe symptoms and lower quality of life which have not responded to more than 6 months’ western medical therapy (acid suppression) were improved.
Lee52) (2005) F/78 (n=1) 57 days herbal decoction (Daebowonjeon, Sameumjeon, Oeumjeon) Clinical symptoms (nausea, vomitting) were improved. Hematologic findings and biochemistry findings got in normal range.
Baek53) (2004) M/65 (n=1) 50 days herbal decoction (Yanggyuksan, Yanggyuksanhwa-tang, Jaeumganghwa-tang plus Seongsimsan, Hwangnyeonsobi-hwan, Banhasasim-tang), acupuncture (CV12, ST25, LI4, LR3, SP36, PC6, SP4), moxibustion (CV12, CV8, CV4), cupping (Back-Shu Points, GV9), aromatherapy clinical symptoms were improved.
Case series
Lee54) (2017)
  • ① F/75

  • ② F/50

  • ③ F/53

2 weeks herbal decoction (Ojeok-san plus Saengmaek-san), acupuncture (LI4, LR3, CV13, CV12, CV10, CV17, PC6, LI11, ST36, SP6) Cough VAS decreased.
LCQ-K increased.
Ha55) (2017) n=12 4 weeks herbal decoction (Lijin-tang-gamibang) Clinical characteristics were improved (acid regurgitation and heartburn).
Each symptom score of NDI-K, KGSRS, NRS, SQDQ, and PGIC showed significant advances.
Lim56) (2015)
  • ① F/51

  • ② M/60

  • ① 20 days

  • ② 16 days

  • ① herbal decoction (Soyangin Hyeongbangjihwang-tang), acupuncture (CV12, BL21, ST40, ST36, ST43, ST44, HT7, SP4, PC6), cupping (BL20, BL21, BL18, BL19), medication (4 days)

  • ② herbal decoction (Soyangin Hyeongbangjihwang-tang), acupuncture (CV12, BL21,ST40, ST36, ST43, ST44)

A female patient’s symptoms such as dyspepsia, chest discomfort were almost cured. But they increased with patient’s emotional state repeatedly. A male patient’ symptoms such as abdominal pain, dyspepsia, nausea, heart burn were successfully disappeared.
Kim57) (2015)
  • ① F/49

  • ② F/52

  • ③ F/44

  • ④ F/66

  • ① 26 days

  • ② 31 days

  • ③ 15 days

  • ④ 13 days

  • ① herbal decoction (Insambaekhab-tang), Herbal Formulae (Opaesan plus Jakyakgamcho-tang-gagam-bang, SokPyeonAnGel, SPAG)

  • ② herbal decoction (Pyeongyoesan-gagam), Herbal Formulae (Opaesan plus Jakyakgamcho-tang-gagam-bang, SokPyeonAnGel, SSPAG)

  • ③ herbal decoction (Bojungikgi-tang, GwakHyang-JungGiSan), Herbal Formulae (Opaesan plus Jakyakgamcho-tang-gagam-bang, SokPyeonAnGel, SPAG), acupuncture, pharmacoacupuncture (junggihaham)

  • ④herbal decoction (Danchisoyosan), Herbal Formulae (Opaesan plus Jakyakgamcho-tang-gagam-bang, SokPyeonAnGel, SPAG), acupuncture, pharmacoacupuncture (junggihaham)

GerdQ scores decreased.
Kim58) (2005)
  • ① M/43

  • ② M/35

  • ③ F/29

  • ④ M/28

  • ⑤ M/28

  • ⑥ F/28

  • ⑦ F/36

3 months herbal decoction (lijintang-gamibang), acupuncture (ST40, CV12, CV14, ST36, GB28, LR4, BL21, BL23) The clinical progress (Ordinal Scales VI Grade and VAS) were improved.
Assessment scales study
Han59) (2015) n=23 The study developed a standard tool for pattern identification of gastroesophageal reflux disease (PIGERD) for standardized diagnosis.
Four pattern identifications [pattern/syndrome of liver qi invading the stomach (肝胃不和), spleen-stomach weakness (脾胃虛弱), spleen-stomach dampness-heat (脾胃濕熱), and stomach yin deficiency (胃陰不足)] and 49 symptoms were then selected.
Choi60) (2022) n=50 The questionnaire showed that the reorganized standard tool had high reliability and moderate validity.(Cronbach alpha=0.834, intra class correlation coefficient of 0.907)
Comparative study
Baek61) (2019) n=29 1 year the GERD with globus senstion group (GS group)
the GERD without globus senstion grou p (non-GSgroup)
The duration of the symptom in the GS group was significantly longer than that in the non-GS group. In HRV parameters, the non-GS group showed a significantly higher value of total power and high frequency than the GS group.
Table 5
Clinical Symptoms of Gastroesophageal Reflux Disease
Author (year) case number clinical symptoms
heartburn regurgitation chest pain abdominal pain dysphagia cough globus nausea
Kim43) (2021) 1 1 1 1 1
Kim44) (2021) 1 1 1 1 1
Jun45) (2020) 1 1 1
Na46) (2017) 1 1 1
Lee47) (2017) 1 1 1 1 1
Yoon48) (2016) 1 1 1
Kim49) (2016) 1 1 1 1 1 1
Kim50) (2011) 1 1 1 1 1
Park51) (2006) 1 1 1 1
Lee52) (2005) 1 1
Baek53) (2004) 1 1 1 1 1 1
Lee54) (2017) 3 3
Ha55) (2017) 12 7 9 4 3 4 4
Lim56) (2015) 2 1 2 1 1
Kim57) (2015) 4 4 4 2 1 2
Kim58) (2005) 7 7 7 7 7 6 6 7
Baek61) (2019) 29 20 5 9 3
total 26 44 17 33 7 14 18 13
Table 6
The Pattern Identification of Gastroesophageal Reflux Disease
Frequency (time) Pattern identification
4 脾胃虛弱(脾氣虛, 氣虛, 脾氣虛), 氣鬱痰阻(肝氣鬱結, 中焦痰火, 食積痰)
3 脾胃濕熱(胃熱)
2 瘀血(血瘀)
1 胃陰虛, 肝胃不和, 少陽人 身寒腹痛亡陰證, 少陽人 身熱頭痛亡陰證, 太陰人 燥熱證 (太陰人 肝受熱 裡熱病 肺燥肝熱證), 少陰人 太陰病痞滿證, 少陰人 裡寒病
Table 7
List of Herbal Medication in Clinical Treatments of Study Case
Frequency (time) Herb medication
4 半夏瀉心湯
2 芍藥甘草湯, 平胃散, 消積健脾丸, 二陳湯
1 太陰人 淸心蓮子湯, 正傳加味二陳湯, 比和飮 桂枝半夏生薑湯, 歸脾湯, 安中散, 蔘出健脾湯, 半夏厚朴湯 茯苓飮, 香砂養胃湯 大補元煎 三陰煎, 五陰煎, 涼膈散, 凉膈散火湯 滋陰降火湯 合 醒心散, 黃連消痞丸, 五積散 合 生脈散, 少陽人 荊防地黃湯, 人參百合湯, 藿香正氣散, 丹梔消遙散, 熱多寒少湯, 手拈散 合 增味二陳湯
Table 8
List of Herbal Name
Frequency (time) Herb name
22 甘草 (Glycyrrhizauralensis)
15 茯苓 (Poria cocas Wolf.)
14 白朮 (Atractylodes japonica Koidzumi)
13 生薑 (Zingiberofficinale)
12 陳皮 (CitrusunshiuMarkovich)
11 人蔘 (Panaxginseng)
9 半夏 (Pinelliaternate), 大棗(Zizyphusjujuba Mill)
8 白芍藥 (Paeoniajaponica)
6 厚朴1 (Machilusthunbergii), 當歸 (Angelica gigas Nakai), 砂仁 (Amomumxanthoides)
5 蒼朮 (Atractylodes japonica), 黃芩 (Scutellariabaicalensis), 地黃 (Rehmannia glutinosa (Gaertn.) Libosch.)
4 藿香(Agastacherugosa), 桂枝 (Cinnamomi Ramulus), 乾薑(Zingiber officinale), 神麯 (Massa Medicata Fermentata)
3 桔梗 (Platycodon grandiflorum A. De Candolle), 薄荷(Mentha canadensis L.), 梔子(Gardenia jasminoides Ellis), 麥門冬 (Liriope platyphylla), 木香 (Aucklandialappa Decaisne), 白芷 (Angelicae Dahuricae Radix), 山楂 (Crataeguspinnatifida Bunge), 麥芽 (Hordeum vulgare Linné), 山藥(Disocoreabatatas), 遠志 (Polygala tenuifolia), 酸棗仁 (Ziziphi Spinosae Semen), 枳實(Poncirustrifoliata Rafinesque), 五味子 (Schisandra chinensis)
2 連翹 (Forsythiae Frucus), 川芎 (Cnidiumofficinale), 香附子 (Cyperusrotundus L.), 枳殼 (poncirus trifoliata), 紫蘇葉 (Perilla frutescens Britton var. acuta Kudo), 黃連 (Coptis japonica), 蘿蔔子(Raphanus sativus L.), 葛根(Puerarialobata), 白豆蔲 (Amomum cadamomum), 知母 (Anemarrhena asphodeloides Bunge), 天門冬 (Asparagus cochinchinensis), 石菖浦 (Acorus gramineus), 龍眼肉 (Longanae Arillus)
Table 9
List of Acupoints in Clinical Treatments
Frequency (time) Acupoints
11 足三里 (ST36)
8 中脘 (CV12)
5 合谷 (LI4) 太衝 (LR3) 內關 (PC6)
4 孔孫4 (SP4)
3 三陰交 (SP6) 上脘 (CV13) 下院 (CV10)
2 太陽 (EX-HN5) 中封 (LR4) 豊隆 (ST40) 胃兪 (BL21)
1 巨闕 (CV14) 人迎 (ST9) 水突 (ST10) 上巨虛 (ST37) 解谿 (ST41) 內庭 (ST44) 陷谷 (ST43) 勞宮 (PC8) 大陵 (PC7) 少府 (HT8) 行間 (LR2) 經渠 (LU8) 膻中(CV7) 曲池 (LI11) 維道 (GB28) 腎兪 (BL23) 脾兪 (BL20) 肝兪 (BL18) 肺兪 (BL13)
Table 10
Clinical Progress
Author (year) Case number Clinical symptoms
heartburn regurgitation chest pain abdominal pain dysphagia cough globus nausea
Kim43) (2021) 1 GSRS5 →3 GSRS5 →3 GSRS6 →3 + →− ++ →− GSRS3 →2
Kim44) (2021) 1 VAS6.1 →2.6 VAS5.5 →2.1 VAS4.2 →3.4 VAS4.4 →2.2
RSI 27 →14, EQ-5d 0.553 →0.712
Jun45) (2020) 1 100% →65% NRS8 →0 100% →65%
KGSRS 49 →35, GIS 16 →9, FD-QoL 20 →25
Na46) (2017) 1 VAS10 →0 VAS10 →1
FSSG 39 →5
Lee47) (2017) 1 ++ →+ +++ →+ ++ →+ ++ →+
VAS80 →35, GSRS (improved/unknown) GIS(improved/unknown)
Yoon48) (2016) 1 +++ →− ++ →−
endoscopy, electrogastrography, enterotachography findings: normal
Kim49) (2016) 1 NRS10 →1 loss NRS10 →7 loss
Kim50) (2011) 1 loss loss loss unchanged
electrogastrography: normal
Park51) (2006) 1 + →− + →− +++ →± ++ →−
Lee52) (2005) 1 loss
Hematologic findings(HGB, HCT, MCV, MCH, MCHC) and biochemistry findings (Protein, total albumin, total bilirubin: normal
Baek53) (2004) 1 +++ →± +++ →± ++ →+ ++ →+ ++ →−
Lee54) (2017) Cough VAS 80 →20
LCQ-K 54 →84
Cough VAS 90 →20
LCQ-K 40 →94
Cough VAS 60 →20
LCQ-K 78→106
Ha55) (2017) 12 NDI-K 57.4±39.9 → 21.5±12.9
KGSRS 25.9±6.0 → 17.6±3.9
NRS 5.8±2.2 → 2.3±1.8
KPSS-10 18.75±3.2 → 16.0±4.0
QSQ 34.3±22.9 → 19.1±11.6
SQDQ 175.0±71.4 → 101.0±53.3
PGIC improved
Lim56) (2015) improved improved
improved improved improved
Kim57) (2015) improved
GerdQ 7 →4
improved unchanged improved improved
GerdQ 8 →5
unchanged unchanged improved improved
GerdQ 8 →6
improved improved
GerdQ 5 →4
Kim58) (2005) VAS10 →0 VAS10 →2 VAS10 →4 VAS10 →7 VAS10 →5 VAS10 →7
VAS10 →3 VAS10 →2 VAS10 →8 VAS10 →6 VAS10 →7 VAS10 →8 VAS10 →5
VAS10 →2 VAS10 →0 VAS10 →7 VAS10 →6 VAS10 →7 VAS10 →5 VAS10 →4
VAS10 →3 VAS10 →2 VAS10 →6 VAS10 →8 VAS10 →2 VAS10 →8
VAS10 →6 VAS10 →0 VAS10 →8 VAS10 →5 VAS10 →8 VAS10 →7 VAS10 →0
VAS10 →3 VAS10 →1 VAS10 →3 VAS10 →3 VAS10 →5 VAS10 →4 VAS10 →3
VAS10 →2 VAS10 →0 VAS10 →5 VAS10 →5 VAS10 →6 VAS10 →0 VAS10 →0

참고문헌

1. Kim JR. 2000. Digestive disease I. Seoul, Korea: Iljogak.


2. Dent J, El-Serag HB, Wallander MA, Johansson S. 2005; Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 54:710–17. 10.1136/gut.2004.051821
crossref

3. Boulton KH, Dettmar PW. 2022; A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Annals of Esophagus. 5:1–10. http://dx.doi.org/10.21037/aoe-20
crossref

4. National health insurance service. Health insurance review & assessment service, 「National Health Insurance Statistical(2020)」. Available from: URL:http://opendata.hira.or.kr/op/opc/olapHifrqSickInfo.do


5. Professors at a national medical school. Current Medical Diagnosis & Treatment(1). Seoul, Korea: Hanwoori;2000. p. 630–5.


6. Ahtaridis G, Snape WJ, Cohen S. 1982; Lower esophageal sphincter pressure as an index of gastro esophageal acid reflux. Dig Dis Sci. 26:993–8. 10.1007/BF01314761


7. Lanas A, Royo Y, Orte GOJ, Molina M, Saintz R. 1999; Experimental esophagitis induced by acid and pepsin in rabbits mimicking human refluxesophagitis. Gastroenterology. 116:97–107. http://doi.org/10.1016/S0016-5085(99)70233-7
crossref

8. Malfertheiner P, Hallerback B. 2005; Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract. 59:346–55. 10.1111/j.1742-1241.2005.00370.x
crossref

9. Pereria RS. 2006; Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin viatamins and aminoacids comparison with omeprazole. J Pineal Res. 41:195–200. 10.1111/j.1600-079X.2006.00359.x
crossref

10. Rao CV, Vijayakumar M. 2008; Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin on experimental reflux esophagitis in rats. Eur J Pharmacol. 589:233–8. https://doi.org/10.1016/j.ejphar.2008.04.062


11. Nam SJ, Park SC, Lee SJ. 2016; Extraesophageal Manifestations of Gastroesophageal Reflux Disease. Korean J Med. 91:3. 257–63. https://doi.org/10.3904/kjm.2016.91.3.257


12. Jeong ID. 2017; A Review of Diagnosis of GERD. Korean J Gastroenterol. 69:2. 96–101. https://doi.org/10.4166/kjg.2017.69.2.96


13. Jo YJ. 2013; Proton Pump Inhibiter for Gastroesophageal Reflux Disease : Intelligent prescription. Korean J of Internal Medicine. 84:2. 186–95. https://doi.org/10.3904/kjm.2013.84.2.186


14. Nigam HS, Paea LP, Anna BM, Yohannes TG, Srinivasan VL, Jake M, editors. 2015. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One. 10:6. p. 1–16. https://doi.org/10.1371/journal.pone.0124653


15. Hamed K, Edward SH, Brian CJ, Carlos AC, Diane F, Andrew TC. 2012; Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 344https://doi.org/10.1136/bmj.e372


16. National College of Oriental Medicine Gastroenterology class. Oriental gastroenterology. Seou, Korea: Gunja publishers;2008. p. 314–8.


17. Nam HH, Seo YS, Song JH, Lee AY, Noh PR, Moon BC, editors. Crab Water Extrct Ameliorates Reflux Esophagitis in Rats. HerbalFormulaScience. 2022. 30:1. p. 11–8. https://doi.org/10.14374/HFS.2022.30.1.11


18. Lee SH, Lee JA, Shin MR, Lee JH, Rho SS. The Protective Effect of Arecae Semen and Coptidis Rhizoma in a Chronic Reflux Esophagitis Rat Model. J Int Korean Med. 2021; 42:1. 11–24. https://doi.org/10.22246/jikm.2021.42.1.11


19. Lee JA, Shin MR, Rho SS, Park HJ. 2021; Effects of a mixture of Citri Pericarpium and Scutellariae Radix on acute reflux esophagitis in rats. Journal of Nutrition and Health. 54:3. 321–33. https://doi.org/10.4163/jnh.2021.54.3.321


20. Lee JA, Shin MR, Choi JW, Rho SS. 2021; Effect of Toosendan Fructus on Chronic Acid Reflux Esophagitis Rats. Kor. J Herbol. 36:3. 1–8. http://doi.org/10.6116/kjh.2021.36.3.1


21. Lee JA, Shin MR, Lee SN, Park SA, Park HJ. 2020; Effect of a Mixture of Rhei Rhizoma and Scutellariae Radix Extract on Acute Reflux Esophagitis Rats. Kor J Herbol. 35:6. 43–53. https://doi.org/10.6116/kjh.2020.35.6.43


22. Lee SH, Lee JA, Shin MR, Lee JH, Rho SS. 2020; The Protective Effect of Arecae Semen and Coptidis Rhizoma in a Chronic Reflux Esophagitis Rat Model. Kor J Herbol. 35:4. 25–36. https://doi.org/10.22246/jikm.2021.42.1.11


23. Lee JA, Oh MH, Shin MR, Rho SS, Park HJ. 2021; Effect of Rhei Rhizoma and Scutellariae Radix Mixture in Chronic Acid Reflux Esophagitis Rats. Kor J Pharmacogn. 52:3. 177–85. https://doi.org/10.22889/KJP.2021.52.3.177


24. Nam HH, Seo YS, Lee JH, Seo YH, Yang SG, Moon BC, editors. 2020. Effect on rat model of reflux esophagitis treated with Charybdis japonica extract. Kor J Herbol. 35:4. p. 17–23. http://dx.doi.org/10.6116/kjh.2020.35.4.17


25. Shin MR, Lee JA, Kim MJ, Ahn HJ, Rho SS. 2020; The protective effect of Areca Semen and Toosendan Fructus mixture in a chronic model of reflux esophagitis. Kor J Herbol. 35:1. 57–68. http://dx.doi.org/10.6116/kjh.2020.35.1.57


26. Lee SH, Baek TH. 2019; A Comparative Study on the Effects of Pinellia ternata, Zingiber officinale and Sobanhatang on Reflux Esophagitis. The Journal of Korean Medicine. 40:2. 17–34. https://doi.org/10.13048/jkm.19014
crossref

27. Lee JA, Park HJ, Kim SH, Kim MJ, Kim KJ, Shin MR, editors. 2019. Evaluation of Evodiae Fructus Extract on the Chronic Acid Reflux Esophagitis in Rats. Kor J Herbol. 34:2. p. 15–23. http://dx.doi.org/10.6116/kjh.2019.34.2.15


28. Kim SH, Rho SS, Lee JA, Shin MR, Lee AR, Koo JS, editors. Improving Effects on Rats with Chronic Acid Reflux Esophagitis Treated of Coptidis Rhizoma Extract. Kor J Herbol. 34:1. p. 117–24. http://dx.doi.org/10.6116/kjh.2019.34.1.117


29. Song CH, Baek TH. 2018; A Comparative Study of Sepiae Os, Arcae Concha, Ostreae Concha and Esomeprazole in a Mouse Model of Reflux Esophagitis. The Journal of Korean Medicine. 39:2. 92–105. https://doi.org/10.13048/jkm.18018
crossref

30. Kwon OJ, Lee AR, Rho SS. 2016; Improving Effects on Rats with Reflux Esophagitis Treated with Combined Extract of Young persimmon fruit and Citrus pee.l. Kor J Herbol. 31:1. 25–31. http://dx.doi.org/10.6116/kjh.2016.31.1.25
crossref

31. Shin MH, Kim ES, Lee YS. 2016; Suppressive Effects of Ulmi Pumilae Cortex Extracts on the Reflux Esophagitis in Rat. J Physiol & Pathol Korean Med. 30:4. 257–65.
crossref

32. Lee JY, Seo BI, Rho SS. 2016; Improving effect of Artemisiae Capillaris Herba extract in reflux esophagitis rats. Kor J Herbol. 31:6. 37–44. http://dx.doi.org/10.6116/kjh.2016.31.6.37
crossref

33. Shin MK, Kim ES, Kim TR, Lim HC, Lee YS. 2016; Effects of Jwa Kum-Whan on Reflux Esophagitis in Rats. J Int Korean Med. 37:3. 495–507.


34. Lee SG, Lim SW. 2016; The Administration of Jeungmiyijin-tang to Rats with Induced Gastro Reflux Esophagitis. Korean J. Orient Int Med. 37:6. 1030–41. https://doi.org/10.22246/jikm.2016.37.6.1030


35. Kim MY, Shin YO, Lee JY, Lee AR, Shin SH, Kwon OJ, editors. 2015. Improving Effect of a Combined Extract of Rhei Rhizoma and Glycyrrhizae Rhizoma through Anti-oxidative Stress in Reflux Esophagitis rats. Kor J Herbol. 30:4. p. 37–44. http://dx.doi.org/10.6116/kjh.2015.30.4.37
crossref

36. Lee ST, Kwak MA. 2013; Effects of Individual Herbal Components of Yijintang-gamibang in the Rat Reflux Esophagitis. Korean J. Orient Int Med. 34:2. 165–77.


37. Choi YJ, Jung TY, Lim SC. 2013; nhibitory Effects of Naegwan-acupuncture (PC6) on Acute Reflux Esophagitis Rat. Journal of Korean Acupuncture & Moxibustion Medicine Society. 30:2. 31–41.


38. Jang MW, Lim SW. 2013; Experimental Study for Effect of Banhasasim-tang on Mice with Reflux Esophagiti. Korean J. Orient. Int Med. 34:4. 362–74.


39. Kim DJ, Rho SS. 2012; Effect on Acute reflux Esophagitis by Evodiae Fructus Aquous Extract. Kor. J Herbol. 227:1. 51–8. https://doi.org/10.6116/kjh.2012.27.1.51
crossref

40. Kim HJ, Lim SY, Kwak MA, Kim DJ, Byun JS. 2010; Korean J. Orient. Int. Med. Korean J. Orient. Int Med. 31:1. 128–41.


41. Lee YJ, Park JH, Rho SS. 2010; Effects on Rats with Reflux Esophagitis Treated with Lonicerae Flos Extract. Korean J Oriental Physiology & Pathology. 24:6. 970–5.


42. Park K, Kwak MA, Kim DJ, Byun JS. 2010; Protective Effects of Yijin-tang-gamibang Aqueous Extracts on Reflux Esophagitis Mediated by Antioxidant Defense Systems. Korean J. Oriental Physiology & Pathology. 24:3. 416–25.


43. Kim MS, Lee IH, Yeum JY, Lee KL, Park SJ. 2021; A Case Report of Taeumin Patient with Gastroesophageal reflux disease Treated with Taeumin Cheongsimyeonja-tang. J Sasang Constitut Med. 33:4. 57–64. https://doi.org/10.7730/JSCM.2021.33.4.57


44. Kim SW, Kong GS, Song JY, Park JH, Wang YM, Kim SY, editors. 2021. A Case Report on Reflux Esophagitis Treated with Korean Medicine in a Patient with Spinal Stenosis. Korean J. Orient. Int. Med. 42:5. p. 800–7. https://doi.org/10.22246/jikm.2021.42.5.800


45. Jun HJ, Kim KJ, Cho MJ, Ko SJ, Park JW. 2020; A Case Report of Non-cardiac Chest Pain in a Non-erosive Reflux Disease Patient Treated with Beewha-eum. Korean J. Orient. Int. Med. 41:6. 1223–30. https://doi.org/10.22246/jikm.2020.41.6.1223


46. Na GY, Park HS, Moon YH. 2017; A Case Report on Soojeom-san plus Jeungmiyijin-tang for Treatment of Gastroesophageal Reflux Disease with Hiatal Hernia. Korean J. Orient. Int. Med. 38:3. 401–7. https://doi.org/10.22246/jikm.2017.38.3.401


47. Lee JH, Cho SH, Ko SJ, Park JW. 2017; Clinical Case Report of PPI-refractory Gastro-Esophageal Reflux Disease (GERD) with Korean Medicine Treatment - A Focus on Evaluation of the Abdominal Examination. Korean J. Orient. Int. Med. 38:5. 727–35. https://doi.org/10.22246/jikm.2017.38.5.727


48. Yoon SH. 2016; A Clinical Case Report of Endoscopic Reflux Esophagitis with Gastric Dysmotility Treated with Korean Traditional Medical Therapy. Korean J. Orient. Int. Med. 37:4. 669–77. https://doi.org/10.22246/jikm.2016.37.4.669


49. Kim YJ, Park JS, Sung HK, Lee JA, Kim DH, Go HY. 2016; A Case Report of Gastroesophageal Reflux Disease and Dysphagia Caused by Ingestion of Detergent. Korean J. Orient. Int. Med. 37:5. 855–62. https://doi.org/10.22246/jikm.2016.37.5.855


50. Kim YH, Kim SY, Hwang MW. 2011; A Case Study of Taeumin Patient with Gastro-esophageal reflux disease(GERD) who Treated Successfully with Yeoldahanso-tang (Reduohanshao -tang). J of Sasang Constitutional Medicine. 23:1. 132–8.


51. Park JW, Yoon SW. 2006; A Clinical Case Report of Non-erosive Reflux Disease Treated with Traditional Oriental Medicine. Korean J. Orient. Int. Med. 27:4. 991–8.


52. Lee JE, Park JH, Cho HS, Kim JC, Oh SW, Lee SH, editors. 2005. Case Report of Gastroesophageal Reflux Disease(GERD) with Hiatal Hernia. Korean J. Orient. Int. Med. 26:1. p. 244–51.


53. Baek DG, Hwang SI, Rim EK, Lee YJ, Cho YK, Moon MH, editors. 2004. Clinical Study on 1 Case of Reflux Esophagitis. Korean J. Oriental Physiology & Pathology. 18:6. p. 1933–7.


54. Lee JH, Bhang YH, Kim JH, Do HW, Kim KI, Jung HJ, editors. 2017. Case Study of Three Gastro-esophageal Reflux-induced Chronic Cough Patients Treated with Ojeok-san plus Saengmaek-san. Korean J. Orient. Int. Med. 38:4. p. 520–530. https://doi.org/10.22246/jikm.2017.38.4.520


55. Ha NY, Han GJ, Kim DJ, Ko SJ, Park JW, Kim JS. 2017; Case Series of Refractory Gastroesophageal Reflux Disease Treated with Lijin-tang-gamibang. Korean J. Orient. Int. Med. 38:6. 1085–95. https://doi.org/10.22246/jikm.2017.38.6.1085


56. Lim TH, Park HS. 2015; 2 Case Reports of Gastroesophageal Reflux Disease Diagnosed as Soyangin Mangeum. J Sasang Constitut Med. 27:2. 297–306. https://doi.org/10.7730/JSCM.2015.27.2.297
crossref

57. Kim MJ, Jang IS, Kang SY. 2015; A Case Study of 4 Patients with Reflux Esophagitis Who Had Improved Gastroesophageal Reflux Disease after Treatment with SokPyeonAnGel. Korean J. Orient. Int. Med. 36:1. 40–8.


58. Kim BS, Lim HY, Oh JH, Kim DW, Choi BH, Hur JI, editors. 2005. Seven Cases of Non-Erosive Gastroesophageal Reflux Disease Who were Treated by Ljintang-Gamibang and Acupuncture. Korean J. Orient. Int. Med. 26:4. p. 926–34.


59. Han GJ, Leem JT, Lee NR, Kim JS, Park JW, Lee JH. 2015; Development of a Standard Tool for Pattern Identification of Gastroesophageal Reflux Disease (GERD). Korean J. Orient. Int. Med. 36:2. 122–52.


60. Choi YJ, Ha NY, Ko SJ, Park JW, Kim JS. 2022; A Study of the Reliability and Validity of Standard Tools for the Pattern Identification of Gastroesophageal Reflux Disease. Korean J. Orient. Int. Med. 43:1. 1–21. https://doi.org/10.22246/jikm.2022.43.1.1


61. Baej SY, Hwang MN, Ko WH, Kim DY, Lee HN, Jeong HI, editors. 2019. Comparison of the Clinical Characteristics of Patients with Gastroesophageal Reflux Disease According to Globus Sensation. Korean J. Orient. Int. Med. 40:3. p. 287–94. https://doi.org/10.22246/jikm.2019.40.3.287


62. Vela MF. 2014; Diagnostic work-up of GERD. Gastrointest Endoscopy Clin N Am. 24:655–66. 10.1016/j.giec.2014.07.002
crossref

63. Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, editors. 2005. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 100:p. 747–53. 10.1111/j.1572-0241.2005.41245.x
crossref

64. Kim N, Lee SW, Cho SI, Yang CH, Kim HS, Rew JS, editors. 2008. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 27:p. 173–85. 10.1111/j.1365-2036.2007.03561.x
crossref

65. Institute of Medical Information Science. disease-visible-1 digestive system. MEDIC MEDIA;2010. p. 40


66. Soon Chun Hyang University, College of Medicine The Institution of Gastroenterology. Gastroenterology. Seoul, Korea: Medical Book Publisher;2000. p. 165–70.


67. Fitoshi S. the 6th volume of internal medicine understood as Pathophysiology. Seoul, Korea: Jungdam publishers;2002. p. 54–5.


68. Lee JH. 2010; Medical Treatment of Gastroesophageal Reflux Disease: How to Do Early Treatment and Maintenance Therapy. The Korean journal of gastroenterology. 55:4. 26–30.


69. Son JI, Kim JJ, Park MK, Han SH, Kim JE, Lee JW, editors. 2004. The Natural History of Asymptomatic Reflux Esophagitis; A retrospective study from periodic health checkup program. Korean Journal of Neurogastroenterology and Motility. 10:2. p. 100–4.


70. Cho SH, Kim JY, Yeo EJ, Han YH. 2011; A case of erosive reflux esophagitis associated with upper gastrointestinal bleeding. Korean J Orient.Int Med. 32:1. 257–63.


71. Yang EJ, Seo JW, Woo YJ, et al. 2011; Five cases study of Parkinson’s disease patients who complain vomiting & anorexia treated with herbal medicine Beewhaeum. Korean J Orient.Int Med. 32:1. 152–60.


72. Itzkowitz SH, Yio X. 2004; Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 287:1. 7–17. 10.1152/ajpgi.00079.2004
crossref

73. Baeuerle PA, Baltimore D. 1996; NF-κB: Ten years after. Cell. 87:13–20. 10.1016/s0092-8674(00)81318-5
crossref

74. Farhadi A, Fields J, Banan A, Keshavarzian A. 1996; Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus and the Latter’s progression toward Esophageal cancer? Am J Gastroenterol. 97:22–6. 10.1111/j.1572-0241.2002.05444.x
crossref

75. Lee JS, Oh TY, Au Y, Foo LY. 2000; Antioxidant and radical scavenging activities of polyphenols from apple pomace. Food Chem. 68:81–5. https://doi.org/10.1016/S0308-8146(99)00167-3
crossref

76. Cha JY, Kim HJ, Chung CH, Cho YS. 1999; Antioxidative activities and contents of polyphenolic compound of Cudrania tricuspidata. J Korean Soc Food Sci Nutr. 28:1310–5.


77. Heim KE, Tagliaferro AR, Bobilya DJ. 2002; Flavonoid antioxidants: Chemistry, metabolism, and structure activity relationships. J Nutr Biochem. 13:572–84. 10.1016/s0955-2863(02)00208-5
crossref

78. Shin DY, Yoon MK, Choi YW, Gweon OC, Kim JI, Choi TH, editors. 2010. Effects of Aged Black Garlic Extracts on the Tight Junction Permeability and Cell Invasion in Human Gastric Cancer Cells. Journal of Life Science. 20:4. p. 528–34. https://doi.org/10.5352/JLS.2010.20.4.528
crossref

79. Racke K, Riemann A, Schworer H, Kilbinger H. 1996; Regulation of 5-HT release from enterochromaffin cell. Behav Brain Res. 73:83–7. 10.1016/0166-4328(96)00075-7


80. Saegusa Y, Takeda H, Muto S, Oridate N, Nakagawa K, Sadakane C, editors. 2011. Decreased motility of the lower esophageal sphincter in a rat model of gastroesophageal reflux disease may be mediated by reductions of serotonin and acetylcholine signaling. Biol Pharm Bull. 34:5. p. 704–11. 10.1248/bpb.34.704
crossref

81. Professors of Oriental Medial Prescription at the Oriental Medicine University. Oriental Medical Prescription. Seoul, Korea: Daesung publishers;1993. p. 112–3. p. 116–7.


82. Jeon SY, Kim WB, Seok EJ, Song SY, Jeong JG, Lee SI. 2018; An analysis of clinical studies on Banha-Sasim-Tang. Herbal Fomula Science. 26:3. 267–81. https://doi.org/10.14374/HFS.2018.26.3.267


83. Heo J. Donguibogam. Seoul, Korea: Bubin publishers;2005. p. 2135–7.


84. Korean Medicine Textbook Compilation Committee. Herbal pharmacology. Seoul, Korea: Shinilboooks;2006. p. 49–53. p. 115–21. p. 234–6. p. 279–82. p. 561–2. p. 586p. 613–9.


85. Yoon GY. Oriental medical Prescription. Seoul, Korea: Myunbo publishers;1985. p. 85–90.


86. Kim HA. 1989. The Effect of Ijintang on Gastrointestinal Exercise and Gastrointestinal Secretion in White rat. Master’s thesis. Wonkwang University.


87. Lee JC. 1983. Effect of Jeungmi-Ijintang on experimental gastric ulcer in white rat. Master’s thesis. Wonkwang University.


88. Professors of Herbology at National College of Oriental Medicine. Herbology. Seoul, Korea: Younglim publishers;1998. p. 136–7. p. 302–4. p. 347–9. p. 448–9. p. 540–1.


89. a textbook compilation committee of herbal pharmacology. herbal pharmacology. Seoul, Korea: Shinil books;2010. p. 247–8. p. 579p. 641–2.


90. Merdians& Acupoints Compilation Committee of Korean Medical Colleges. Principles of meridians & acupoints: a guidebook for college students. Daejeon, Korea: Jongryenamu;2012. p. 64–7. p. 213–6. p. 918–21. p. 998–9.


91. Wu LL, Lin Z. 2014; Recent advances in treatment of gastroesophageal reflux disease by acupuncture. World Chinese Journal of Digestology. 22:36. 5631–5. 10.11569/wcjd.v22.i36.5631
crossref

Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953.journal@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI